These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8726005)

  • 1. Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays.
    Venkateswarlu K; Denning DW; Manning NJ; Kelly SL
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1382-6. PubMed ID: 8726005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans.
    Yang HC; Mikami Y; Yazawa K; Taguchi H; Nishimura K; Miyaji M; Branchini ML; Aoki FH; Yamamoto K
    Mycoses; 1998 Dec; 41(11-12):477-80. PubMed ID: 9919890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei.
    Venkateswarlu K; Denning DW; Kelly SL
    J Antimicrob Chemother; 1997 Jun; 39(6):731-6. PubMed ID: 9222042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H; Belanger P; Fratti R; Ghannoum M
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antifungal activities of D0870 against fluconazole-resistant Candida albicans].
    Kojima M; Yamada H; Nakamura S; Kikuchi M; Nakanishii T; Takahashi Y; Mochizuki H; Mikami Y
    Nihon Ishinkin Gakkai Zasshi; 1999; 40(4):209-15. PubMed ID: 10536307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata.
    Pfaller MA; Bale MJ; Buschelman B; Rhomberg P
    Diagn Microbiol Infect Dis; 1994 Jun; 19(2):75-80. PubMed ID: 7805359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong antifungal activity of SS750, a new triazole derivative, is based on its selective binding affinity to cytochrome P450 of fungi.
    Matsumoto M; Ishida K; Konagai A; Maebashi K; Asaoka T
    Antimicrob Agents Chemother; 2002 Feb; 46(2):308-14. PubMed ID: 11796335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
    Wardle HM; Law D; Moore CB; Mason C; Denning DW
    Antimicrob Agents Chemother; 1995 Apr; 39(4):868-71. PubMed ID: 7785986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance.
    Alvarez-Rueda N; Fleury A; Logé C; Pagniez F; Robert E; Morio F; Le Pape P
    Med Mycol; 2016 Oct; 54(7):764-775. PubMed ID: 27143634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
    Barchiesi F; Colombo AL; McGough DA; Fothergill AW; Rinaldi MG
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2553-6. PubMed ID: 7872746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
    Cartledge JD; Denning DW; Dupont B; Clumeck N; De Wit S; Midgley J; Hawkins DA; Gazzard BG
    AIDS; 1998 Mar; 12(4):411-6. PubMed ID: 9520171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
    Venkateswarlu K; Denning DW; Kelly SL
    J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of fluconazole resistance in Candida krusei.
    Orozco AS; Higginbotham LM; Hitchcock CA; Parkinson T; Falconer D; Ibrahim AS; Ghannoum MA; Filler SG
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2645-9. PubMed ID: 9756770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation of intracellular structure corresponding to reduced affinity of fluconazole for cytochrome P-450 in two low-susceptibility strains of Candida albicans isolated from a Japanese AIDS patient.
    Maebashi K; Kudoh M; Nishiyama Y; Makimura K; Kamai Y; Uchida K; Yamaguchi H
    Microbiol Immunol; 2003; 47(2):117-24. PubMed ID: 12680714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Y132H substitution in Candida albicans sterol 14alpha-demethylase confers fluconazole resistance by preventing binding to haem.
    Kelly SL; Lamb DC; Kelly DE
    FEMS Microbiol Lett; 1999 Nov; 180(2):171-5. PubMed ID: 10556708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of mechanisms of fluconazole resistance in a Candida albicans isolate from a Japanese patient with chronic mucocutaneous candidiasis.
    Kamai Y; Maebashi K; Kudoh M; Makimura K; Naka W; Uchida K; Yamaguchi H
    Microbiol Immunol; 2004; 48(12):937-43. PubMed ID: 15611610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G464S amino acid substitution in Candida albicans sterol 14alpha-demethylase causes fluconazole resistance in the clinic through reduced affinity.
    Kelly SL; Lamb DC; Loeffler J; Einsele H; Kelly DE
    Biochem Biophys Res Commun; 1999 Aug; 262(1):174-9. PubMed ID: 10448088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans.
    Hitchcock CA; Dickinson K; Brown SB; Evans EG; Adams DJ
    Biochem J; 1990 Mar; 266(2):475-80. PubMed ID: 2180400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species.
    Barry AL; Brown SD
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1948-9. PubMed ID: 8843312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.